PIERUZZI, FEDERICO UMBERTO EMILIO GUGLIE
 Distribuzione geografica
Continente #
NA - Nord America 12.418
AS - Asia 7.251
EU - Europa 5.605
SA - Sud America 1.168
AF - Africa 173
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 7
AN - Antartide 1
Totale 26.637
Nazione #
US - Stati Uniti d'America 12.143
SG - Singapore 2.657
CN - Cina 1.607
IT - Italia 1.178
HK - Hong Kong 983
BR - Brasile 892
VN - Vietnam 883
RU - Federazione Russa 869
DE - Germania 850
SE - Svezia 576
IE - Irlanda 519
UA - Ucraina 331
FR - Francia 311
GB - Regno Unito 275
IN - India 244
AT - Austria 214
CA - Canada 157
BD - Bangladesh 122
FI - Finlandia 117
AR - Argentina 109
TR - Turchia 101
IQ - Iraq 98
KR - Corea 97
JP - Giappone 88
ID - Indonesia 77
MX - Messico 69
NL - Olanda 68
ES - Italia 67
DK - Danimarca 63
ZA - Sudafrica 60
PK - Pakistan 47
SA - Arabia Saudita 47
CO - Colombia 46
UZ - Uzbekistan 34
PL - Polonia 32
VE - Venezuela 30
EC - Ecuador 28
EG - Egitto 21
PY - Paraguay 21
PH - Filippine 19
CH - Svizzera 17
MA - Marocco 17
CL - Cile 16
ET - Etiopia 16
JM - Giamaica 16
BE - Belgio 15
DZ - Algeria 15
MY - Malesia 15
GR - Grecia 14
NP - Nepal 14
PE - Perù 14
PT - Portogallo 14
PS - Palestinian Territory 13
LT - Lituania 12
OM - Oman 12
TH - Thailandia 12
TN - Tunisia 11
AU - Australia 10
AE - Emirati Arabi Uniti 9
KE - Kenya 9
PA - Panama 9
IL - Israele 8
IR - Iran 8
AL - Albania 7
CZ - Repubblica Ceca 7
KG - Kirghizistan 7
KZ - Kazakistan 7
LB - Libano 7
NO - Norvegia 7
RO - Romania 7
UY - Uruguay 7
CR - Costa Rica 6
JO - Giordania 6
RS - Serbia 6
AZ - Azerbaigian 5
DO - Repubblica Dominicana 5
EU - Europa 5
HU - Ungheria 5
BO - Bolivia 4
NZ - Nuova Zelanda 4
AO - Angola 3
BG - Bulgaria 3
BH - Bahrain 3
BY - Bielorussia 3
HR - Croazia 3
LV - Lettonia 3
MM - Myanmar 3
NG - Nigeria 3
SC - Seychelles 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
CY - Cipro 2
EE - Estonia 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
ME - Montenegro 2
MN - Mongolia 2
MU - Mauritius 2
Totale 26.600
Città #
Ann Arbor 2.328
Singapore 1.624
Ashburn 1.093
Hong Kong 963
Fairfield 670
Woodbridge 670
San Jose 609
Chandler 562
Dallas 514
Frankfurt am Main 503
Dublin 502
Houston 485
Wilmington 473
Jacksonville 298
Seattle 297
New York 296
Beijing 274
Ho Chi Minh City 274
Dearborn 261
Milan 258
Cambridge 222
Chicago 198
Santa Clara 196
Princeton 195
Vienna 193
The Dalles 188
Hefei 184
Los Angeles 178
Hanoi 171
Nanjing 143
Lauterbourg 113
Lawrence 92
Altamura 91
São Paulo 91
Seoul 89
Moscow 77
Shanghai 72
Council Bluffs 70
Buffalo 66
San Diego 55
Guangzhou 51
Jakarta 50
Tokyo 49
Dong Ket 48
Lachine 43
Nanchang 43
Orem 43
Rome 41
London 40
Helsinki 39
Baghdad 38
Boardman 37
Falls Church 37
Haiphong 36
Da Nang 35
Munich 33
Lissone 32
Shenyang 32
Andover 31
Jinan 31
Pune 31
Tashkent 31
Nuremberg 30
Tianjin 29
Brooklyn 27
Montreal 27
Changsha 26
Salt Lake City 25
Toronto 25
Ottawa 24
Zhengzhou 24
Columbus 23
Dhaka 23
Johannesburg 23
Jeddah 22
San Francisco 22
Warsaw 22
Denver 21
Rio de Janeiro 21
Tampa 21
Atlanta 20
Belo Horizonte 20
Chennai 20
Hebei 20
Manchester 19
New Delhi 19
Ningbo 19
Hangzhou 18
Istanbul 18
Phoenix 18
Kunming 17
Turku 17
Brasília 16
Mumbai 16
Norwalk 16
Stockholm 16
Biên Hòa 15
Brussels 15
Campinas 15
Fremont 15
Totale 17.273
Nome #
Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis 684
Polymethylmethacrylate membrane and serum free light chain removal: enhancing adsorption properties 503
Molecular Pathways and Respiratory Involvement in Lysosomal Storage Diseases 497
The putative role of MALDI-MSI in the study of Membranous Nephropathy 417
Microscopic Polyangiitis 407
MALDI-MSI Approach to Renal Biopsies of Patients with Fabry Disease 387
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 386
MALDI imaging in Fabry nephropathy: a multicenter study 384
Combined Plasmatic and Tissue Approach to Membranous Nephropathy-Proposal of a Diagnostic Algorithm Including Immunogold Labelling: Changing the Paradigm of a Serum-based Approach 373
Kidney Involvement 368
Children of a lesser god or miracles? An emotional and behavioural profile of children born to mothers on dialysis in Italy: A multicentre nationwide study 2000-12 355
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 355
The role of blood pressure, body weight and fat distribution on left ventricular mass, diastolic function and cardiac geometry in children 352
Diagnostic specificity of autoantibodies to M-type phospholipase A2 receptor (PLA2R) in differentiating idiopathic membranous nephropathy (IMN) from secondary forms and other glomerular diseases 346
Outcomes on safety and efficacy of left atrial appendage occlusion in end stage renal disease patients undergoing dialysis 346
Proteomics for the study of new biomarkers in Fabry disease: State of the art 337
Maternal perception of excess weight in children: a survey conducted by paediatricians in the province of Milan 305
ANG II increases TIMP-1 expression in rat aortic smooth muscle cells in vivo 303
Usefulness of waist circumference for the identification of childhood hypertension 299
Multicenter evaluation of use of dried blood spot compared to conventional plasma in measurements of globotriaosylsphingosine (LysoGb3) concentration in 104 Fabry patients 294
Fusarium solani infection after antimicrobial treatment of a severe bacterial peritonitis: a case report and review of the literature 287
Insulin resistance, prehypertension, hypertension and blood pressure values in paediatric age 286
Obesity-associated hypertension in childhood: A new epidemic problem 282
Radiation dose from medical imaging in end stage renal disease patients: a Nationwide Italian Survey 280
A case series of chronic haemodialysis patients: mortality, sudden death, and QT interval 277
Clinicopathological characteristics of typical and atypical anti-glomerular basement membrane nephritis 276
Corpus callosum involvement: a useful clue for differentiating Fabry Disease from Multiple Sclerosis 272
Intrafamilial phenotypic variability in four families with Anderson-Fabry disease 269
α-1-Antitrypsin detected by MALDI imaging in the study of glomerulonephritis: Its relevance in chronic kidney disease progression 269
Progression of obstructive ventilatory disorder in Fabry disease: Only a matter of time? 268
QT interval prolongation and decreased heart rate variability in cirrhotic patients: relevance of hepatic venous pressure gradient and serum calcium 254
Ramipril and Cardiovascular Outcomes in Patients on Maintenance Hemodialysis: The ARCADIA Multicenter Randomized Controlled Trial 250
Protein-Bound Uremic Toxins and Inflammation Process in Hemodialysis Patients: Is There a Role for Adsorption Hemodiafiltration? 246
Angiotensin II modulates calponin gene expression in rat vascular smooth muscle cells in vivo 246
Atrial fibrillation in end stage renal disease patients: influence of hemodialysis on P wave duration and atrial dimension 245
Electrophysiological evidence of ipsilateral reno-renal reflexes in the cat 243
Results of blood pressure screening in a population of school-aged children in the province of Milan: role of overweight 242
Parapelvic cysts, a distinguishing feature of renal Fabry disease 242
Routine immunohistochemical staining in membranous nephropathy: in situ detection of phospholipase A2 receptor and thrombospondin type 1 containing 7A domain 237
Role of fat distribution indicators in the identification of hypertension in children 235
Sympathetic activation in cardiovascular and renal disease 234
FAbry STabilization indEX (FASTEX): An innovative tool for the assessment of clinical stabilization in Fabry disease 233
Implant success and safety of left atrial appendage occlusion in end stage renal disease patients: Peri-procedural outcomes from an Italian dialysis population 232
Renal afferents signaling diuretic activity in the cat 228
Renal afferents responsive to chemical and mechanical pelvic stimuli in the rabbit 227
Outcome of Different Induction Regimens in Anca-Associated Glomerulonephritis According to the Histopathological Characteristics: the Reassess Study* 227
Adrenergic overdrive in mild renal failure: Regional patterns and relationships with metabolic and cardiac abnormalities 226
New insights from the application of the FAbry STabilization indEX in a large population of Fabry cases 226
Improving the Annotation Process in Computational Pathology: A Pilot Study with Manual and Semi-automated Approaches on Consumer and Medical Grade Devices 223
Identification of Four New Mutations in the GLA Gene Associated with Anderson–Fabry Disease 222
Sympathetic activation and heart rate thresholds for cardiovascular risk in chronic kidney disease 222
Blood Pressure Responses to Renal Denervation Precede and Are Independent of the Sympathetic and Baroreflex Effects 219
Warped-average template technique to track on a cycle-by-cycle basis the cardiac filling phases on left ventricular volume 218
Pulmonary and renal neutral endopeptidase EC 3.4.24.11 in rats with experimental heart failure 215
Monoclonal gammopathy of renal significance: Systemic involvement by benign condition 215
Effects of polymerization on the hypertensive action of diaspirin cross-linked hemoglobin in rats 214
Tubulointerstitial lesions in lupus nephritis: International multicentre study in a large cohort of patients with repeat biopsy 212
Trabecular complexity as an early marker of cardiac involvement in Fabry disease 211
ANCA-associated vasculitis in childhood: Recent advances 208
Anticoagulant-related nephropathy: a pathological note 208
Best practices on pregnancy on dialysis: the Italian Study Group on Kidney and Pregnancy 204
Tumour incidence in Fabry disease: A cross-sectional study 204
Angiotensin II increases tissue inhibitor matrix metalloproteinase-2 (TIMP-2) gene expression in rat aorta in vivo 200
Early recognition of airway obstruction in Fabry disease and correlation with dyspnea: A case series 200
Analysis of heart period and arterial pressure variability in childhood hypertension: Key role of baroreflex impairment 198
Avacopan for the treatment of ANCA-associated vasculitis 198
Primary Sclerosing Cholangitis and Amyloid A Amyloidosis: Association or Coincidence? 196
Redefining the pulvinar sign in fabry disease 196
Interpretation of GFR slope in untreated and treated adult Fabry patients 195
Neuronal nitric oxide synthase and renin stimulation by sodium deprivation are dependent on the renal nerves 194
La terapia enzimatica sostitutiva nella malattia di Fabry 194
Hypertension in childhood: autonomic and metabolic patterns 192
MALDI imaging mass spectrometry in glomerulonephritis: feasibility test 192
La diagnosi precoce di malattia 187
Effects of cyclosporin A on the synthesis, excretion, and metabolism of endothelin in the rat 186
A novel missense mutation for Fabry disease detected by echocardiographic screening in left ventricular hypertrophy patients 186
[Clinical and histological findings in Fabry nephropathy] 182
Effects of adenosine receptor agonists on efferent renal nerve activity in anesthetized rats 179
Role of the renal nerves in the control of renin synthesis during different sodium intakes in the rat 176
Mutations in the GLA gene and LysoGb3: Is it really Anderson-Fabry disease? 175
Elevated Ambulatory Blood Pressure Measurements are Associated with a Progressive Form of Fabry Disease 175
Possible Pathogenetic Relationship between Fabry Disease and Renal Cell Carcinoma 174
Effects of erythropoietin administration on blood pressure and urinary albumin excretion in rats 173
Angiotensin II modulates MMP-2/TIMP-2 gene expression in rat aorta in vivo 173
Phenotypic characteristics of the p.Asn215Ser (p.N215S) GLA mutation in male and female patients with Fabry disease: A multicenter Fabry Registry study 173
Reducing agalsidase beta infusion time in Fabry patients: low incidence of antibody formation and infusion-associated reactions in an Italian multicenter study 171
A morphological classification of the fat particles found in the urinary sediment of patients with Fabry disease 167
Correction to: Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy (Journal of Nephrology, (2023), 36, 7, (2013-2022), 10.1007/s40620-023-01708-7) 163
PICC insertion and veins of the arm size variation during dialysis treatment: A prospective observational study 162
Intraoperative diagnosis of Anderson-Fabry disease in patients with obstructive hypertrophic cardiomyopathy undergoing surgical myectomy 162
Angiotensin II increases calponin expression in cultured rat vascular smooth muscle cells 161
Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial 160
Expression of renin-angiotensin system components in the heart, kidneys, and lungs of rats with experimental heart failure 160
Erratum: Erratum to: Relapsing Minimal Change Disease Superimposed on Late-Onset p.N215S Fabry Nephropathy (Clinical Kidney Journal (2022) 15:4 (839) DOI: 10.1093/ckj/sfab148) 156
Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy 156
Safety of a protocol for reduction of agalsidase beta infusion time in Fabry disease: An Italian multi-centre study 155
The children of dialysis: Live-born babies from on-dialysis mothers in Italy - An epidemiological perspective comparing dialysis, kidney transplantation and the overall population 153
Impact of COVID-19 vaccines in patients on hemodialysis: an Italian multicentre cohort study 148
Effect of Migalastat on cArdiac Involvement in FabRry Disease: MAIORA study 148
Long-term safety and efficacy of left atrial appendage occlusion in dialysis patients with atrial fibrillation: a multi-center, prospective, open label, observational study 142
Totale 24.390
Categoria #
all - tutte 86.413
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 86.413


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021350 0 0 0 0 0 0 0 0 0 0 148 202
2021/20221.614 155 198 187 148 115 140 47 81 73 91 117 262
2022/20232.290 255 725 192 177 154 357 27 115 157 15 55 61
2023/20241.660 56 46 53 81 191 506 288 56 119 31 42 191
2024/20254.413 266 395 261 189 345 148 270 133 511 813 402 680
2025/20269.381 1.145 705 1.059 976 1.185 499 1.470 550 840 815 137 0
Totale 27.248